Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Ajer Jeffrey Robert Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 318 shares @ $66.878, valued at $21.3k
Sold 5,000 shares @ $90, valued at $450k
03/17/2023 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 10,110 shares @ $0
Paid exercise price by delivering 3,971 shares @ $87.74, valued at $348.4k
Paid exercise price by delivering 20,510 shares @ $93.41, valued at $1.9M
Granted 23,070 options to buy @ $87.74, valued at $2M
03/02/2023 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 20,760 shares @ $0
Granted 10,380 shares @ $0
Granted 7,629 shares @ $0
01/27/2023 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 44,825 shares @ $115.654, valued at $5.2M
Sold 4,175 shares @ $116.154, valued at $484.9k
Exercised 2,200 options to buy @ $67.81, valued at $149.2k
Exercised 46,800 options to buy @ $67.81, valued at $3.2M
11/04/2022 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 3,000 shares @ $86.12, valued at $258.4k
09/26/2022 4 Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 4,198 shares @ $3.16, valued at $13.3k
09/20/2022 4 Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 10,200 shares @ $0
Granted 20,400 options @ $3.47, valued at $70.8k
08/12/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/31/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2022 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 1,180 shares @ $82.47, valued at $97.3k
03/31/2022 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 1,618 shares @ $79.43, valued at $128.5k
Sold 1,381 shares @ $79.56, valued at $109.9k
03/24/2022 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 2,073 shares @ $81, valued at $167.9k
Sold 6,129 shares @ $81.78, valued at $501.2k
03/17/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/28/2021 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 342 shares @ $62.407, valued at $21.3k
Sold 2,739 shares @ $73.6, valued at $201.6k
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/09/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/01/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/23/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/19/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/17/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/15/2020 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 2,121 shares @ $79.91, valued at $169.5k
09/30/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/25/2020 4/A Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
09/24/2020 4 Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Granted 9,100 shares @ $0
Granted 18,200 options @ $18.91, valued at $344.2k
09/21/2020 4 Ajer Jeffrey Robert (Director) has filed a Form 4 on NEKTAR THERAPEUTICS
Txns: Sold 2,250 shares @ $19.74, valued at $44.4k
06/23/2020 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Granted 338 shares @ $62.586, valued at $21.2k
Sold 15,000 shares @ $124, valued at $1.9M
Exercised 15,000 options to buy @ $63.1, valued at $946.5k
04/09/2020 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 2,407 shares @ $79.98, valued at $192.5k
04/02/2020 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 1,537 shares @ $82, valued at $126k
03/26/2020 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Sold 2,041 shares @ $74.36, valued at $151.8k
Sold 1,618 shares @ $78.47, valued at $127k
03/24/2020 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Paid exercise price by delivering 3,599 shares @ $73.05, valued at $262.9k
03/17/2020 4 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) has filed a Form 4 on BIOMARIN PHARMACEUTICAL INC
Txns: Paid exercise price by delivering 7,644 shares @ $84.5, valued at $645.9k
Granted 10,380 shares @ $0
Granted 29,590 options to buy @ $73.82, valued at $2.2M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy